As Pfizer and Biontech, amongst others, announce their promising Covid-19 vaccine candidate, the world sees a functioning vaccine on the horizon. Judging from current reportings, it could be as soon as January 2021.
As trusted certified (GDP, ISO, and AEO) advisors in the world of logistics and innovative disruptors in a traditional industry, YSDS is already putting all our expert minds together to work out the best logistical solutions for this type of transport.
The conclusion? We think there’ll be three main factors to take into consideration when it comes to the transportation of Pfizer’s vaccine:
- Temperature: The requirement that the vaccine has to be kept in an environment of -78 degrees Celsius is the largest risk factor. If temperatures deviate, the product may be destroyed.
- Speed: It’s important that the vaccine will get to people on time, to ensure help reaches those who need it.
- Backlog: The transport requires huge amounts of both packaging and dry ice – a demand most producers will find difficult to meet. Demand will be bigger than the production speed, and we’re already hearing stories about for example dry ice producers receiving large orders they can’t keep up with.
So why is YSDS the right logistics partner for the job?
Ahead of each transport we always carry out a risk assessment and mitigation to judge the product we are to transport, its specific needs, and how we can meet the required specifications. Furthermore, we always take all foreseeable risks into account and plan for eventual obstacles to the best of our ability.